C-VaLo
C-VaLo is a publicly funded French technology transfer office in Tours, created in 2019, that supports academic researchers across 9 member institutions in Centre-Val de Loire by funding IP protection, technology maturation, and licensing or startup creation.
- Company typePrivate
- Founded2019
- HeadquartersTours, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What C-VaLo does
C-VaLo (Centre-Val de Loire Transfert et Valorisation) is a publicly funded technology transfer office headquartered at MAME, 49 Boulevard Preuilly, Tours, France. Created in April 2019 as a public investment device under the auspices of Université de Tours, it is operationally a regional transfer vehicle serving academic researchers across nine member institutions in the Centre-Val de Loire region: Université de Tours, Université d'Orléans, CHRU Tours, CHU Orléans, INSA Centre-Val de Loire, CNRS, INRAE, Inserm, and BRGM. Its mission is to identify commercially promising academic inventions, protect intellectual property (50 patent applications filed to date across 377 investigated projects), improve technology readiness through pre-maturation and maturation funding, and transfer innovations to market via licensing or startup creation.
C-VaLo does not develop its own product technology; it is an intermediary that supports the maturation of academic IP across health, life sciences, engineering, green tech, digital, and humanities/social sciences. Its portfolio spans 23+ named projects including OHMBOX (residential energy storage), ADC4GEN (immuno-conjugates for oncology), PELICAN (glioblastoma treatment), FUSBRAIN (ultrasound drug delivery), PCC (interventional neuroradiology planning), LOCASARM (vine-shoot biopesticide), and I-COM (eye-tracking for immobilized patients), of which five (OHMBOX, BKSTRIP, MAGIC ELEC, PCC, FUSBRAIN) have already been transferred to market. Spinoff startups including SPRINXELLE, SPyDiag, Bionumetics, MS4ALL, and VIEWaves illustrate the research-to-entrepreneurship pathway.
C-VaLo's business model is managed services for the public sector. It receives grant-based funding from PIA (Programme d'Investissements d'Avenir), France 2030, the Région Centre-Val de Loire, and FEDER (European Regional Development Fund), and deploys that capital as non-dilutive pre-maturation (€1,630,265 cumulative) and maturation (€8,210,850 cumulative) investments into academic projects. Services are delivered at no direct cost to researchers. Distribution is exclusively institutional — direct engagement through each member institution's partenariat/valorisation service, regional innovation events (VivaTech, COSM'INNOV, MEET2WIN), and coordination within the PUI Loire Valley Innov' ecosystem alongside TT Booster, Da Vinci Labs, DEV'UP, La French Tech Val de Loire, and Cosmetic Valley.
C-VaLo firmographics
Firmographics- Name
- C-VaLo
- Legal name
- Université de Tours
- Website
- https://c-valo.fr
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- C-VaLo is a publicly funded French technology transfer office in Tours, created in 2019, that supports academic researchers across 9 member institutions in Centre-Val de Loire by funding IP protection, technology maturation, and licensing or startup creation.
- Ownership category
- akta.pro rank
C-VaLo industry classification
Industry- Product category
- Technology Transfer Services
- NAICS
- Other Financial Vehicles (52599), Portfolio Management and Investment Advice (523940)
- SIC
- Investors, Nec (6799)
- akta.pro primary industry
- SDG / Thematic Sustainable Investment Funds (FSANAJAN)
- akta.pro secondary industry
- Corporate Strategic Real Assets & Infrastructure Venture Investing (FSANAHAN)
Keywords
Where C-VaLo is headquartered
LocationHeadquarters
- HQ city
- Tours
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
C-VaLo business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Public investment funding: C-VaLo is a publicly funded technology transfer device. It receives operational and investment funding from government programs including PIA (Programme d'Investissements d'Avenir), France 2030, the Région Centre-Val de Loire, and FEDER (European Regional Development Fund). It deploys this funding as pre-maturation (early-stage feasibility) and maturation (technology development) investments in academic research projects to bring them to commercial readiness.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
C-VaLo product offering
Product offeringCore offering
C-VaLo is a public investment device that supports the transfer of academic research results to socio-economic applications. It identifies inventions arising from regional research labs, protects intellectual property, advances technology readiness through pre-maturation and maturation funding, and facilitates commercialization via licensing agreements or the creation of spin-off startups. Its portfolio spans health, life sciences, engineering, green tech, digital technologies, and humanities/social sciences across the Centre-Val de Loire region.
Product overview
C-VaLo is a public investment device created in April 2019, supported by PIA, France 2030, and the Centre-Val de Loire Region. It is not a traditional software product company but rather a technology transfer organization that protects intellectual property, improves technological maturity, and facilitates the commercialization of academic research innovations. C-VaLo supports a portfolio of 23+ technology projects spanning health/oncology, agriculture, environment, engineering, and digital technologies, including PAR Oncologie, Monocats, PEPCAN, QuickMabCOVID, ADC4GEN, SAChA, THERMOFRELON, Pharsim, NEBPET, PLASFIBRES, LOCASARM, DBNO, I-COM, MOLINOV, PELICAN, TOAST, VAChT, CYCLOp, and transferred technologies OHMBOX, BKSTRIP, MAGIC ELEC, PCC, and FUSBRAIN. The organization operates across the full technology transfer value chain from identification of uses and markets, through intellectual property protection, value creation, maturation, and final transfer to industry.
Differentiator
Problem solved
Functional benefit
Products and services
- OHMBOX Power conversion system for autonomous and intelligent residential energy storage. Marketed as a Transferred Technology with license signed.
- ADC4GEN Optimization of immunoconjugates for therapeutic and diagnostic applications, including breast cancer.
- SAChA Innovative Solutions Targeting Influenza Infection.
- PELICAN New treatment against glioblastoma.
- FUSBRAIN New drug delivery device using ultrasound technology. Marketed as a Transferred Technology.
- PCC Planning and management tool for interventions in Interventional Neuro-Radiology. Marketed as a Transferred Technology.
- BKSTRIP New technology for tracking BK virus in kidney transplant recipients. Marketed as a Transferred Technology.
- MAGIC ELEC BIM extension for detector placement in digital models. Marketed as a Transferred Technology.
- PAR Oncologie Enhanced cross-city/hospital monitoring system for patients treated on an outpatient basis for oncology care.
- Monocats Recombinant gonadotropins replacing PMSG for controlling reproduction in livestock farming.
- PEPCAN Demonstration of therapeutic efficacy of peptides in oncology.
- CYCLOp Traceability system for mineral materials in transformed products.
- QuickMabCOVID Development of monoclonal antibodies against COVID-19 variants.
- THERMOFRELON Innovative ecological system for destroying hornet and wasp nests.
- Pharsim Biological preparation simulator for practical work in health sciences.
- NEBPET Treatment against asthma in animals.
- PLASFIBRES Feasibility study of plasma functionalization and coating of textile fibers.
- LOCASARM Development of biopesticide extracted from vine shoots in a circular economy framework.
- DBNO Optimization of thrust from a dual-humped propulsion nozzle via secondary fluid injection, transition control, and vectoring.
- MOLINOV New molecule for the treatment of pain.
- VAChT Diagnostic and therapy solutions for neuropathologies.
- I-COM Personalized eye tracking system for better communication with immobilized patients.
- TOAST Test object for quality control of MRI acquisition sequences for stereotactic applications.
Quantifiable outcome
- 377 projects investigated; 50 patent applications filed; €9,841,115 total investments deployed; multiple technologies transferred including OHMBOX (license signed), BKSTRIP, MAGIC ELEC, PCC, FUSBRAIN
Companies that use C-VaLo
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
C-VaLo technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature23 records
C-VaLo partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered core, supporting and minor.
- Loire Valley Innov' (Pôle Universitaire d'Innovation)coreC-VaLo is a founding member of the PUI Loire Valley Innov', a university innovation pole that brings together regional academic institutions and partners to coordinate technology transfer, startup support, and innovation ecosystem development. C-VaLo serves as the vehicle for IP protection and technology maturation within this structure.
- TT BoostersupportingTT Booster is an Appel à Manifestation d'Intérêt (AMI) program that identifies and supports new project creation from research. C-VaLo works in complement with TT Booster, which handles startup creation support, while C-VaLo manages IP protection and maturation.
- Da Vinci LabssupportingDa Vinci Labs runs the Da Vinci Launchpad bootcamp program for deeptech startup creation (covering synthetic biology, AI, and quantum technologies). C-VaLo refers researchers to this complementary program and works in interaction with Da Vinci Labs within the Loire Valley Innov' PUI framework.
- Université de TourscoreUniversity of Tours is one of C-VaLo's two founding university members. C-VaLo's Director of Publication is the President of Université de Tours. The university hosts C-VaLo's headquarters and provides institutional infrastructure.
- Université d'OrléanscoreUniversity of Orléans is one of C-VaLo's two founding university members. Its valorisation service works in direct coordination with C-VaLo staff to support researchers.
- CNRS (Centre National de la Recherche Scientifique)coreCNRS is one of four research establishment members of C-VaLo, contributing researchers and labs to the technology transfer pipeline. C-VaLo coordinates with CNRS's innovation and transfer structures.
- INRAE (Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement)coreINRAE is a research establishment member of C-VaLo contributing researchers in agriculture, food, and environmental sciences to the technology transfer program.
- Inserm (Institut National de la Santé et de la Recherche Médicale)coreInserm is a research establishment member of C-VaLo contributing health and medical researchers to the technology transfer program.
- BRGM (Bureau de Recherches Géologiques et Minières)coreBRGM is a research establishment member of C-VaLo contributing researchers in geology and mineral resources to the technology transfer program.
- CHRU de Tours (Centre Hospitalier Régional Universitaire de Tours)coreCHRU de Tours is one of two hospital center members of C-VaLo, contributing clinical research and healthcare innovation to the transfer pipeline.
- CHU Orléans (Centre Hospitalier Universitaire d'Orléans)coreCHU Orléans is one of two hospital center members of C-VaLo, contributing clinical research capacity to the technology transfer program.
- INSA Centre-Val de Loire (Institut National des Sciences Appliquées)coreINSA Centre-Val de Loire is the grande école member of C-VaLo, contributing engineering research capacity to the technology transfer program.
- DEV'UP Centre-Val de LoiresupportingDEV'UP is the regional development agency for Centre-Val de Loire. C-VaLo collaborates with DEV'UP on regional innovation events including VivaTech and the Before VivaTech regional showcase.
- La French Tech Val de LoiresupportingLa French Tech Val de Loire is a regional French Tech community promoting tech startups. C-VaLo works with this network for joint visibility at events like VivaTech.
- Cosmétosciences / Cosmetic ValleysupportingC-VaLo partners with Cosmétosciences and Cosmetic Valley to jointly promote cosmetics-related academic technologies at the COSM'INNOV congress in Orléans.
- ANRT (Association Nationale de la Recherche et de la Technologie)minorC-VaLo participates in ANRT innovation events, including the cocktail event 'Construire durable, innover à l'échelle du secteur' focused on sustainable construction innovation, held at Leonard (VINCI's urban innovation hub).
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
C-VaLo competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
C-VaLo social profiles
Digital presenceC-VaLo financial estimates
Financial estimateRevenue estimate
Valuation estimate
C-VaLo leadership team
Management profileNumber of profiles
Profiles11 records
C-VaLo funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
C-VaLo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about C-VaLo
What does C-VaLo do?
C-VaLo is a public investment device that supports the transfer of academic research results to socio-economic applications. It identifies inventions arising from regional research labs, protects intellectual property, advances technology readiness through pre-maturation and maturation funding, and facilitates commercialization via licensing agreements or the creation of spin-off startups. Its portfolio spans health, life sciences, engineering, green tech, digital technologies, and humanities/social sciences across the Centre-Val de Loire region.
Is C-VaLo a public or private company?
C-VaLo is a private company. It is classified as state government owned and is currently operating.
When was C-VaLo founded?
C-VaLo was founded in 2019. It employs 11 to 50 people.
Where is C-VaLo based?
C-VaLo is headquartered in Tours, France, in the Europe region.
How does C-VaLo make money?
One revenue line is on record: public investment funding.
Does C-VaLo have an API?
No public API is recorded for C-VaLo.
What industry is C-VaLo in?
C-VaLo's product category is Technology Transfer Services. Its primary akta.pro industry code is FSANAJAN, SDG / Thematic Sustainable Investment Funds, with a secondary code of FSANAHAN, Corporate Strategic Real Assets & Infrastructure Venture Investing. Its NAICS code is 52599 and its SIC code is 6799.